Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease (STROLL)

NCT00739102 is registered in ClinicalTrials.gov with Cordis US Corp. as lead sponsor.

NCT NCT00739102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00739102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease (STROLL)
Lead sponsor
Cordis US Corp.
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2008
Completion date
April 30, 2013
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

superficial femoral artery disease